Columbus, OH

Insider

The FDA just approved a colon-cancer blood test. It could save people from spending hundreds of dollars on tests or relying on a colonoscopy alone.

A new blood test can spot signs of colon cancer in your annual blood draw

Washington, DC

DC News Now

WASHINGTON (DC News Now) — A new blood test may make it much easier and cheaper to screen for signs of colon cancer. Test manufacturer Guardant said the Food and Drug Administration (FDA) approved its Shield test for screening in adults 45 years and older who have an average risk of colon cancer. The test […]

FDA approves first blood test screening for colon cancer

Approval marks the first time an immuno-oncology regimen has demonstrated a survival benefit for all adults with primary advanced or recurrent endometrial cancer, company says. The FDA has approved an expanded indication for GSK’s Jemperli (dostarlimab) to include treatment of all adults with primary advanced or recurrent endometrial cancer. According...

FDA Expands Approval of GSK’s Jemperli in Combination with Chemotherapy for Adults with Primary Advanced or Recurrent Endometrial Cancer

A JAMA Network Open study finds that noninvasive at-home colorectal cancer screening can reduce death risk by 33%. Researchers from Ohio State University and Kaiser Permanente analyzed data from 11,000 patients, showing FIT’s annual effectiveness equals a ten-year colonoscopy. The study stresses improving accessibility and addressing racial disparities in cancer screening.

At-Home Colon Cancer Test Proves Just As Effective as a Colonoscopy

Stage 3 colorectal cancer means the cancer has spread to the nearby lymph nodes, but it has not spread to distant parts of the body. Colorectal cancer is a type of cancer that starts in the colon or rectum. Depending on where it begins, people may refer to it as colon cancer or rectal cancer.

What to know about stage 3 colorectal cancer

Biomarkers, molecules found in blood or other biological tissues that signal a condition, disease, or process, are very valuable in helping doctors recommend the most effective treatment for a patient. One way in which biomarkers inform treatment decisions is when a specific biological marker correlates to a likelihood of responding to a certain therapy. Thus, understanding biomarkers has become a crucial component of personalized medicine.

A 10-Gene Signature Can Signal Chemotherapy Response in Colon Cancer

Verywell Health

The FDA approved the first blood test for screening colorectal cancer. In a clinical trial, the test identified 83% of the colorectal cancer cases and delivered false positive results to 10% of cancer-free participants. The blood test isn't a substitute for a colonoscopy, but it could improve screening rates among...

You Can Now Get a Blood Test to Screen for Colorectal Cancer

Experts in hematology, gastroenterology, and obstetrics and gynecology detail their experiences with the real-world application of intravenous iron in their clinics. Video content above is prompted by the following questions:. Addressing the real-world application in your clinic, how many infusions are needed and what is the cost? What is the...

Real-World Applications of Intravenous Iron

Cervical cancer screening is a crucial health measure for women. It helps detect abnormal cells in the cervix that could develop into cancer. Regular screening can save lives by catching issues early when they are most treatable. There are two main types of tests: the Pap test and the HPV test. The Pap test looks for precancerous changes, while the HPV test checks for the virus that can cause these changes. Women should start getting screened at age 21. Early detection through screening has significantly reduced cervical cancer rates. Knowing the facts about cervical cancer screening can empower women to take charge of their health.

20 Facts About Cervical Cancer Screening

The FDA has approved denileukin diftitox-cxdl for relapsed/refractory cutaneous T-cell lymphoma after at least 1 prior systemic therapy. The FDA has approved denileukin diftitox-cxdl (Lymphir) for the treatment of patients with relapsed/refractory cutaneous T-cell lymphoma (CTCL) after at least 1 prior systemic therapy.1. The approval was supported by data from...

FDA Approves Denileukin Diftitox for R/R Cutaneous T-Cell Lymphoma

Study shows efficacy of olanzapine in improving complete response rates and chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy regimens comprised of oxaliplatin, carboplatin, or irinotecan. A Phase III trial found that adding olanzapine to moderately emetogenic chemotherapy (MEC) regimens consisting of oxaliplatin, carboplatin, or irinotecan, boosted rates...

Addition of Olanzapine Improves Complete Response, Nausea and Vomiting Prevention in Chemotherapy-Naive Patients

In the last 6 months prior to PDAC diagnosis, visceral and subcutaneous adipose tissue decreased by 12.9% and 14.7%, respectively. LDL, total cholesterol and triglycerides also decreased before diagnosis. In the 36 months prior to diagnosis of pancreatic ductal adenocarcinoma, researchers observed “predominant changes” in patients’ body composition and biochemical...

Body fat, metabolic changes before pancreatic cancer diagnosis may aid in early detection

Everyday Health

Hypoglycemia symptoms include having anxiety, emotional instability, dizziness, and lightheadedness. Here's a list with more signs to watch for.

10 Warning Signs of Low Blood Sugar

A phase 2 study found that a combination of pacritinib, sirolimus, and tacrolimus successfully suppressed pSTAT3 and Th1/Th17 cells, but failed to prevent acute graft-versus-host disease following allogeneic transplant. A prophylactic regimen of pacritinib (Vonjo), sirolimus (Rapamune), and tacrolimus (Prograf) suppressed pSTAT3 and Th1/Th17 cells, but did not effectively prevent...

Pacritinib, Sirolimus, and Tacrolimus Combo Fails to Improve GVHD Outcomes

It’s important to communicate with the patient’s comanaging doctors to adjust necessary medications. There are four direct oral anticoagulants approved for atrial fibrillation and venous thromboembolism: apixaban (Eliquis), dabigatran (Pradaxa), edoxaban (Savaysa) and rivaroxaban (Xarelto). Click image to enlarge. The body is an interconnected system and, as clinicians...

Some Blood Thinners May Increase Conversion to Wet AMD

For people who are at high risk of developing pancreatic cancer, regular imaging tests to monitor the pancreas may help detect the disease at an earlier stage than when pancreatic cancer is typically diagnosed in the general population, according to a new study. The study also suggests that detecting pancreatic...

Surveillance for People at High Risk of Pancreatic Cancer

The Hill

The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including anaphylaxis. The agency said it approved Neffy, from ARS Pharmaceuticals, for use in adult and pediatric patients who weigh at least 30...

FDA approves epinephrine nasal spray, a needle-free alternative to EpiPen

Chicago, IL

Writers represent independent, third-party users who have joined our contributor program and self-verified their accounts. Writers are expected, like all users, to adhere to our Community Standards.

writer

Foodie in Chicago

Shortly before 3 AM, people in the Chicago area may have felt their houses shake as a 3.4-magnitude earthquake occurred about 60 miles west of the city. (CHICAGO) The United States Geological Survey (USGS) reported a 3.4-magnitude earthquake around Somonauk, IL. Somonauk is in DeKalb and LaSalle Counties, 64 miles west of Chicago.

Did You Feel the Earthquake?

UPI News

It's long been known that a daily dose of low-dose aspirin helps keep colon cancer at bay. But new research suggests that those who benefit most are people with lifestyles that up their odds for the disease.

Aspirin's role in preventing colon cancer examined

Findings from a prespecified secondary analysis of the reduced-dose cohort of the TESTING trial suggest the efficacy of a lower dose of oral methylprednisolone in IgA nephropathy. A reduced-dose oral methylprednisolone regimen tapered over 6 to 9 months improves kidney outcomes in patients with high-risk IgA nephropathy (IgAN), according to...

Reduced-Dose Methylprednisolone Improves Kidney Outcomes, Delays Renal Failure in High-Risk IgAN

NewsBreak

FDA Approves First Blood Test for Primary Colorectal Cancer Screening

The approval of Guardant Health’s Shield test makes it the first blood test to be approved as a primary screening option for CRC and the first...

FDA Approves First Blood Test for Primary Colorectal Cancer Screening

Comments / 0